Lundin, Magnus
Heiberg, Einar
Nordlund, David
Gyllenhammar, Tom
Steding-Ehrenborg, Katarina
Engblom, Henrik
Carlsson, Marcus
Atar, Dan
van der Pals, Jesper
Erlinge, David
Borgquist, Rasmus
Khoshnood, Ardavan
Ekelund, Ulf
Nickander, Jannike
Themudo, Raquel
Nordin, Sabrina
Kozor, Rebecca
Bhuva, Anish N.
Moon, James C.
Maret, Eva
Caidahl, Kenneth
Sigfridsson, Andreas
Sörensson, Peder
Schelbert, Erik B.
Arheden, Håkan
Ugander, Martin
Funding for this research was provided by:
Stockholms Läns Landsting (20140547)
Karolinska Institutet (Clinical Scientist Training program (M Lundin), 2012)
Vetenskapsrådet (2011-38395-87953-13)
Hjärt-Lungfonden (20170870)
Karolinska Institute
Article History
Received: 1 June 2023
Accepted: 23 November 2023
First Online: 20 December 2023
Competing interests
: ML, JN, RT, EM, KC, AS, PS, and MU are affiliated with Karolinska University Hospital which has a research agreement with Siemens regarding cardiovascular magnetic resonance imaging. EH is the founder of Medviso AB (Lund, Sweden), manufacturer of medical image analysis software. MC and HE have received consultancy fees from Imacor AB (Lund, Sweden) for cardiac MRI analysis. RB has been a speaker consultant for Medtronic (Dublin, Ireland) and for Abbott (Lake Bluff, Illinois, USA), and is on the advisory board for Pfizer (New York, New York, USA). JN has been a speaker for Orion Pharma (Esbo, Finland). HA is a stockholder in Imacor AB (Lund, Sweden). The remaining authors declare no competing interests.